Belbuca and Swallowing difficulty - a phase IV clinical study of FDA data

Summary:

Swallowing difficulty is reported as a side effect among people who take Belbuca (buprenorphine hydrochloride), especially for people who are female, 60+ old, also take Cymbalta, and have Dehydration.

The phase IV clinical study analyzes which people have Swallowing difficulty when taking Belbuca. It is created by eHealthMe based on reports of 2,994 people who have side effects when taking Belbuca from the FDA, and is updated regularly.

What is Belbuca?

Belbuca has active ingredients of buprenorphine hydrochloride. eHealthMe is studying from 3,022 Belbuca users. Check the latest studies of Belbuca.

What is Swallowing difficulty?

Swallowing difficulty is found to be associated with 2,402 drugs and 3,353 conditions by eHealthMe. Check the latest studies of Swallowing difficulty.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 09, 2026

2,994 people reported to have side effects when taking Belbuca.
Among them, 11 people (0.37%) have Swallowing difficulty.

Could Belbuca cause Swallowing difficulty?

Among these 11 people:

What is the gender of people who have Swallowing difficulty when taking Belbuca? *

female: 54.55 %
male: 45.45 %

What is the age of people who have Swallowing difficulty when taking Belbuca? *

What are other drugs people take besides Belbuca? *

Lipitor: 5 people, 45.45%
Cymbalta: 5 people, 45.45%
Hydroxyzine Hydrochloride: 4 people, 36.36%
Xanax: 4 people, 36.36%
Prozac: 4 people, 36.36%
Lunesta: 4 people, 36.36%
Promethazine Hydrochloride: 4 people, 36.36%
Hetlioz: 4 people, 36.36%
Humalog: 3 people, 27.27%
Fludrocortisone Acetate: 3 people, 27.27%

What are other side effects people have besides Swallowing difficulty? *

Nausea And Vomiting: 7 people, 63.64%
Mobility Decreased (ability to move is reduced): 6 people, 54.55%
Nausea (feeling of having an urge to vomit): 6 people, 54.55%
Dizziness: 5 people, 45.45%
Mastication Disorder (disease of chewing food): 5 people, 45.45%
Insomnia (sleeplessness): 5 people, 45.45%
Pain In Extremity: 5 people, 45.45%
Fall: 5 people, 45.45%
Abdominal Discomfort: 4 people, 36.36%
Headache (pain in head): 4 people, 36.36%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 3 people, 27.27%
Dehydration (dryness resulting from the removal of water): 3 people, 27.27%
Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 18.18%
Torticollis (a twisted neck in which the head is tipped to one side, while the chin is turned to the other): 1 person, 9.09%
Pain: 1 person, 9.09%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 9.09%
Hypersensitivity: 1 person, 9.09%
Depression: 1 person, 9.09%
Bipolar Disorder (mood disorder): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Belbuca and have Swallowing difficulty?

- Check whether Swallowing difficulty is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Belbuca:

Belbuca (3,022 reports)

Browse all side effects of Belbuca:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Swallowing difficulty:

Swallowing difficulty (2,402 drugs)

Browse all the conditions that are associated with Swallowing difficulty:

Swallowing difficulty (3,353 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on buprenorphine hydrochloride (the active ingredients of Belbuca) and Belbuca (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.